- Home
- DIT vs ACET Comparison
DIT vs ACET Comparison
Compare DIT & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- ACET
- Stock Information
- Founded
- DIT 1981
- ACET 1947
- Country
- DIT United States
- ACET United States
- Employees
- DIT N/A
- ACET N/A
- Industry
- DIT Food Distributors
- ACET Biotechnology: Pharmaceutical Preparations
- Sector
- DIT Consumer Discretionary
- ACET Health Care
- Exchange
- DIT Nasdaq
- ACET Nasdaq
- Market Cap
- DIT 70.4M
- ACET 63.5M
- IPO Year
- DIT 1995
- ACET N/A
- Fundamental
- Price
- DIT $116.90
- ACET $0.81
- Analyst Decision
- DIT
- ACET Buy
- Analyst Count
- DIT 0
- ACET 5
- Target Price
- DIT N/A
- ACET $5.33
- AVG Volume (30 Days)
- DIT 401.0
- ACET 426.5K
- Earning Date
- DIT 11-07-2025
- ACET 11-05-2025
- Dividend Yield
- DIT 0.86%
- ACET N/A
- EPS Growth
- DIT N/A
- ACET N/A
- EPS
- DIT 2.14
- ACET N/A
- Revenue
- DIT $2,251,684,195.00
- ACET N/A
- Revenue This Year
- DIT N/A
- ACET N/A
- Revenue Next Year
- DIT N/A
- ACET N/A
- P/E Ratio
- DIT $52.04
- ACET N/A
- Revenue Growth
- DIT 7.64
- ACET N/A
- 52 Week Low
- DIT $94.92
- ACET $0.45
- 52 Week High
- DIT $163.75
- ACET $1.57
- Technical
- Relative Strength Index (RSI)
- DIT 52.76
- ACET 56.59
- Support Level
- DIT $117.50
- ACET $0.76
- Resistance Level
- DIT $121.00
- ACET $0.84
- Average True Range (ATR)
- DIT 3.32
- ACET 0.06
- MACD
- DIT -0.37
- ACET 0.00
- Stochastic Oscillator
- DIT 58.33
- ACET 58.16
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.